The FDA spent more than 15 years crafting the guidelines, which are designed to do away with industry practices that downplay ...

Part 2 of this series for Global Biosimilars Week dives into the complexities of payer and pharmacy benefit manager (PBM) ...

Objectives Although financial interactions between physicians and pharmaceutical and medical device companies could be ...

Medicare, a cornerstone of American healthcare, faces a pivotal moment as changes loom for Part D premiums. With the Centers ...